Mutations of IDH1 (codon 132) or IDH2 (codon 172) allow discrimination between two classes of glioblastoma (GBM), IDH-wildtype and IDH-mutant, with differing genomic and epigenomic landscapes and prognoses [5, 7, 8]. This evidence concerns the gene IDH2 and glioblastoma.